Reviewed by:
Prescription required
Ezetimibe is a prescription cholesterol-lowering medication that works by reducing intestinal cholesterol absorption, thereby lowering “bad” LDL and total cholesterol while modestly increasing “good” HDL cholesterol. It can be used alone or with statins to help manage hyperlipidemia or familial high cholesterol and reduce the risk of heart attack and stroke as part of a comprehensive cholesterol-control plan.
Ready to Fill
Ezetimibe
Zetia
Cholesterol absorption inhibitor
Not a controlled medication
Tablets (oral)
For hypercholesterolemia, ezetimibe is typically prescribed at 10 mg taken orally once daily. When used in combination therapy with a statin, the recommended dose remains 10 mg once daily, administered alongside the prescribed statin regimen. For pediatric patients aged 10 years and older with familial hypercholesterolemia, the usual dose is also 10 mg once daily.
Basics
Ezetimibe is a cholesterol-lowering medication used to treat hyperlipidemia by reducing cholesterol absorption from the digestive tract. By limiting cholesterol absorption, ezetimibe helps lower LDL (“bad”) cholesterol levels and supports long-term cardiovascular health.
Unlike statins, which lower cholesterol by decreasing hepatic production, ezetimibe acts at the intestinal level, making it a useful option for patients who cannot tolerate statins or who require additional lipid-lowering beyond statin therapy alone.
Note: This medication’s generic and brand-name formulations are used interchangeably throughout this article.
Zetia is the brand-name formulation of ezetimibe, containing ezetimibe as its active ingredient.
It works by inhibiting the Niemann–Pick C1-like 1 (NPC1L1) protein, which is responsible for cholesterol absorption in the small intestine. This reduces the amount of cholesterol delivered to the liver, ultimately lowering cholesterol levels in the bloodstream.
Zetia may be prescribed alone or in combination with statins to enhance cholesterol reduction and is typically used alongside dietary changes and regular physical activity as part of a comprehensive cardiovascular risk–reduction strategy.
Indications
Zetia is widely recognized for its role in cholesterol management, particularly in lowering various cholesterol parameters to prevent cardiovascular disease.
The primary indication for Zetia is the management of primary hyperlipidemia, in which it is prescribed to reduce elevated levels of total cholesterol, low-density lipoprotein (LDL) cholesterol, and apolipoprotein B. Ezetimibe is used in patients who may not achieve adequate cholesterol control with lifestyle interventions and diet alone.
For individuals with familial hypercholesterolemia, Zetia can be particularly beneficial, often prescribed alongside statins to intensify LDL reduction and improve overall lipid profiles.
Additionally, Zetia is approved for use in patients with homozygous sitosterolemia, a rare inherited condition characterized by elevated blood levels of plant sterols and xanthomas, necessitating specialized treatment approaches to manage cholesterol levels effectively.
Though primarily indicated for hyperlipidemia, Zetia is occasionally used off-label for conditions associated with dyslipidemia. Healthcare providers may consider Zetia in cases of mixed dyslipidemia, where combined lipid abnormalities occur, or when patients exhibit marginal responses to statin therapy alone.
While these applications are not officially approved, clinical considerations based on patient-specific factors often guide such off-label use.
Zetia’s role in managing medication-induced cholesterol elevations, such as those seen in patients undergoing protease inhibitor therapy for HIV, is another potential off-label application.
Mechanism
Understanding how Zetia functions provides insight into its integration in cholesterol management protocols, highlighting its unique contribution to cardiovascular risk mitigation.
Zetia’s mechanism of action centers on its inhibition of the Niemann-Pick C1-like 1 (NPC1L1) protein at the brush border of the small intestine. NPC1L1 is instrumental in the intestinal absorption of cholesterol, facilitating its transport into enterocytes, the cells that line the intestinal wall.
By blocking NPC1L1, ezetimibe prevents these cells from taking up dietary cholesterol and from recycling bile acids. This reduces the delivery of absorbed cholesterol to the liver. The liver, in turn, compensates by increasing clearance of cholesterol from the blood, thereby lowering overall cholesterol levels, particularly LDL cholesterol.
This targeted approach allows Zetia to complement other lipid-lowering strategies, such as statins, which reduce cholesterol production in the liver.
Ezetimibe is well absorbed following oral administration, with bioavailability of approximately 35–65%. Once in the body, it undergoes extensive hepatic and intestinal metabolism to form ezetimibe-glucuronide, its active metabolite. The half-life of ezetimibe averages around 22 hours, providing a suitable pharmacokinetic profile for once-daily dosing.
Elimination pathways involve both biliary and renal excretion, making the dosing adjustments in hepatic or renal impairment situations crucial to avoid potential accumulation.
Dosage
Proper dosing and administration of Zetia are crucial to achieving optimal lipid-lowering outcomes while minimizing side effects.
The standard Zetia regimen is a once-daily dose of 10 mg, whether administered alone or in combination with statins. The 10 mg dose has been demonstrated to effectively reduce LDL cholesterol levels, with substantial evidence supporting its use in combination therapy for particularly challenging cholesterol profiles, such as those in familial hypercholesterolemia.
For specific patient groups, dose adjustments are generally unnecessary; however, healthcare providers should tailor regimens to individual responses and tolerances, particularly when used in combination with other lipid-lowering drugs.
Zetia can be conveniently taken with or without food, allowing flexibility in patient lifestyles and increasing compliance. Consistency is vital to maintaining stable drug levels, so patients are advised to take it at the same time each day.
For patients receiving bile acid sequestrants, Zetia should be administered either 2 hours before or 4 hours after taking these sequestrants due to potential interactions that may affect absorption. These timing considerations ensure maximal absorption and efficacy, preventing a potential reduction in its cholesterol-lowering effects.
New Combination Alert (Nexlizet): A major trend is the use of Nexlizet, a single-pill combination of ezetimibe (Zetia) and bempedoic acid, which offers a statin-sparing approach to cholesterol lowering. This combination can achieve a 35–40% reduction in LDL cholesterol without the muscle-pain risks associated with statins and is increasingly recommended for statin-intolerant patients who require greater LDL lowering than Zetia alone can provide.
Why pay retail prices for the same medication?
At Invictus, we source directly from trusted, FDA-approved manufacturers to keep your costs low without sacrificing quality. Whether you need a one-time fill or regular refills, our transparent pricing makes it easy to save every day.
Side Effects
Knowing the side effects and risks associated with Zetia enables better patient management and the prompt addressing of concerns to maintain adherence and safety.
Zetia is generally well tolerated, but several common side effects may occur:
These effects reinforce the importance of follow-up visits, especially during treatment initiation or dose adjustments.
Serious side effects from Zetia are rare but require immediate medical attention:
Patients should be educated on these risks and advised to report unusual or worsening symptoms promptly.
Interactions
Medication interactions with Zetia are a consideration when using it, requiring diligent management to optimize safety and efficacy.
Effective communication between patients and clinicians ensures coordinated care and minimizes preventable risks. Patients should provide a full list of prescription drugs, OTC medications, and supplements to their healthcare provider for proper interaction screening.
Contraindications
Understanding contraindications helps avoid prescribing Zetia in scenarios where it may cause harm or be ineffective.
Thorough evaluation and continuous monitoring support the safe and effective integration of Zetia into a cholesterol-lowering regimen.
The information provided on this page is for general informational purposes only and is not intended as medical advice. Always consult with a licensed healthcare provider before starting, stopping, or changing any medication regimen. While Invictus strives to provide accurate and up-to-date information, individual health conditions and circumstances vary. The prices, availability, and descriptions of all medications on this page are subject to change.
Your Prescription
Ready to Fill
Need Help?